Grzegorz Sienski, Ph.D.

Director and Project Manager at AstraZeneca

Speaker

Greg leads The Gene Editing Technologies team at AstraZeneca in Göteborg, Sweden, where he develops cutting-edge gene editing tools that enhance the understanding and manipulation of the human genome. After earning his MSc in Biotechnology from Jagiellonian University in Krakow and the Max Planck Institute for Biochemistry in Munich, Greg embarked on a PhD at IMBA in Vienna. His research during this period centered on the transcriptional silencing of transposons in fruit flies. Following his PhD, Greg joined the Whitehead Institute, delving into the molecular underpinnings of brain diseases as a Postdoctoral Fellow. Since joining AstraZeneca in 2019, he has progressed from Associate Principal Scientist to Principal Scientist, and now to Director and Project Leader. Greg is committed to leveraging gene editing technologies to improve human health."